Kathy Eddy has been named chief financial officer at BioConvergence. She will oversee the finance, HR and IT departments. The company noted that this appointment reflects the continued growth of BioConvergence and the increasing scope and complexity of the financial, personnel, and technology requirements within the pharmaceutical industry. “We’re fortunate to have someone with Kathy’s experience, expertise and vision to join our team,” said Alisa Wright, BioConvergence’s chie...